Yuhan Corporation wins Australia patent for anti-ulerant

Yuhan Corporation announced recently that it won a patent from Australia for its novel pyrimidine derivative, known as derivatives of YH1885 (Revanex). It is a reversible proton pump inhibitor which is better effective in inhibiting the secretion of gastric juice than the conventional drugs.

The firm invested a total of 15.0 billion won for the development of the item and plans to commercial...